Response to Krieger et al. Re: “TSHR/IGF-1R Cross-Talk, Not IGF-1R Stimulating Antibodies, Mediates Graves' Ophthalmopathy Pathogenesis” (Thyroid 2017;27:746–747)

Thyroid , Vol. 0, No. 0.


http://ift.tt/2xJ7K1D